1. Agrup G, Andersson T, Falck B, Persson K, Rorsman H, Rosengren E (1975) 5-S-cysteinyldopa in the plasma of melanoma patients and the renal clearance of the amino acid. Acta Derm Venereol (Stockh) 55:5?6
2. Agrup G, Falck B, Hansson C, Rorsman H, Rosengren A-M, Rosengren E (1977) Metabolism of 5-S-cysteinyldopa by Omethylation. Acta Derm Venereol (Stockh) 57:309?312
3. Agrup G, Hansson C, Kennedy B-M, Persson K, Rorsman H, Rosengren A-M, Rosengren E (1976) Analysis of cysteinyldopa isomers and some of their O-methyl derivatives in the urine of melanoma patients by means of gas chromatography-mass spectrometry. Acta Derm Venereol (Stockh) 56:491?492
4. Agrup G, Agrup P, Andersson T, Hafström L, Hansson C, Jacobson S, Jönsson P-E, Rorsman H, Rosengren A-M, Rosengren E (1979) Five years' experience of 5-S-cysteinyldopa in melanoma diagnosis. Acta Derm Venereol (Stockh) 59:381?388
5. Hansson C, Edholm L-M, Agrup G, Rorsman H, Rosengren A-M, Rosengren E (1978) The quantitative determination of 5-S-cysteinyldopa and dopa in normal serum and in serum from patients with malignant melanoma by means of high performance liquid chromatography. Clin Chim Acta 88:419?427